225 related articles for article (PubMed ID: 10027930)
1. Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease.
Hellmark T; Segelmark M; Unger C; Burkhardt H; Saus J; Wieslander J
Kidney Int; 1999 Mar; 55(3):936-44. PubMed ID: 10027930
[TBL] [Abstract][Full Text] [Related]
2. Goodpasture antigen: expression of the full-length alpha3(IV) chain of collagen IV and localization of epitopes exclusively to the noncollagenous domain.
Leinonen A; Netzer KO; Boutaud A; Gunwar S; Hudson BG
Kidney Int; 1999 Mar; 55(3):926-35. PubMed ID: 10027929
[TBL] [Abstract][Full Text] [Related]
3. The Goodpasture autoantigen. Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen.
Kalluri R; Sun MJ; Hudson BG; Neilson EG
J Biol Chem; 1996 Apr; 271(15):9062-8. PubMed ID: 8621555
[TBL] [Abstract][Full Text] [Related]
4. The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain.
Borza DB; Netzer KO; Leinonen A; Todd P; Cervera J; Saus J; Hudson BG
J Biol Chem; 2000 Feb; 275(8):6030-7. PubMed ID: 10681598
[TBL] [Abstract][Full Text] [Related]
5. The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain.
Netzer KO; Leinonen A; Boutaud A; Borza DB; Todd P; Gunwar S; Langeveld JP; Hudson BG
J Biol Chem; 1999 Apr; 274(16):11267-74. PubMed ID: 10196215
[TBL] [Abstract][Full Text] [Related]
6. Immunodominant epitopes of alpha3(IV)NC1 induce autoimmune glomerulonephritis in rats.
Chen L; Hellmark T; Wieslander J; Bolton WK
Kidney Int; 2003 Dec; 64(6):2108-20. PubMed ID: 14633133
[TBL] [Abstract][Full Text] [Related]
7. Molecular mapping of the Goodpasture's epitope for glomerulonephritis.
Bolton WK; Chen L; Hellmark T; Fox J; Wieslander J
Trans Am Clin Climatol Assoc; 2005; 116():229-36; discussion 237-8. PubMed ID: 16555617
[TBL] [Abstract][Full Text] [Related]
8. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition.
Ryan JJ; Mason PJ; Pusey CD; Turner N
Clin Exp Immunol; 1998 Jul; 113(1):17-27. PubMed ID: 9697978
[TBL] [Abstract][Full Text] [Related]
9. Zebrafish to humans: evolution of the alpha3-chain of type IV collagen and emergence of the autoimmune epitopes associated with Goodpasture syndrome.
MacDonald BA; Sund M; Grant MA; Pfaff KL; Holthaus K; Zon LI; Kalluri R
Blood; 2006 Mar; 107(5):1908-15. PubMed ID: 16254142
[TBL] [Abstract][Full Text] [Related]
10. Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies.
Hellmark T; Burkhardt H; Wieslander J
J Biol Chem; 1999 Sep; 274(36):25862-8. PubMed ID: 10464328
[TBL] [Abstract][Full Text] [Related]
11. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays.
Jia XY; Qu Z; Cui Z; Yang R; Zhao J; Zhao MH
Nephrology (Carlton); 2012 Feb; 17(2):160-6. PubMed ID: 21854504
[TBL] [Abstract][Full Text] [Related]
12. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen.
Rutgers A; Meyers KE; Canziani G; Kalluri R; Lin J; Madaio MP
Kidney Int; 2000 Jul; 58(1):115-22. PubMed ID: 10886555
[TBL] [Abstract][Full Text] [Related]
13. Hydrophobic amino acid residues are critical for the immunodominant epitope of the Goodpasture autoantigen. A molecular basis for the cryptic nature of the epitope.
David M; Borza DB; Leinonen A; Belmont JM; Hudson BG
J Biol Chem; 2001 Mar; 276(9):6370-7. PubMed ID: 11098057
[TBL] [Abstract][Full Text] [Related]
14. Molecular properties of the Goodpasture epitope.
Gunnarsson A; Hellmark T; Wieslander J
J Biol Chem; 2000 Oct; 275(40):30844-8. PubMed ID: 10896942
[TBL] [Abstract][Full Text] [Related]
15. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
17. Point mutations of single amino acids abolish ability of alpha3 NC1 domain to elicit experimental autoimmune glomerulonephritis in rats.
Hellmark T; Chen L; Ohlsson S; Wieslander J; Bolton WK
J Biol Chem; 2003 Nov; 278(47):46516-22. PubMed ID: 12970356
[TBL] [Abstract][Full Text] [Related]
18. Quaternary organization of the goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intrapromoter interactions with the alpha4 and alpha5 NC1 domains.
Borza DB; Bondar O; Todd P; Sundaramoorthy M; Sado Y; Ninomiya Y; Hudson BG
J Biol Chem; 2002 Oct; 277(42):40075-83. PubMed ID: 12193605
[TBL] [Abstract][Full Text] [Related]
19. Specificity of Goodpasture autoantibodies for the recombinant noncollagenous domains of human type IV collagen.
Neilson EG; Kalluri R; Sun MJ; Gunwar S; Danoff T; Mariyama M; Myers JC; Reeders ST; Hudson BG
J Biol Chem; 1993 Apr; 268(12):8402-5. PubMed ID: 8473281
[TBL] [Abstract][Full Text] [Related]
20. Precise mapping of the Goodpasture epitope(s) using phage display, site-directed mutagenesis, and surface plasmon resonance.
Gozalbo-Rovira R; Rodríguez-Díaz J; Saus J; Cervera J
Kidney Int; 2013 Mar; 83(3):438-45. PubMed ID: 23254898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
